Metabolic Bone Disease/Osteopenia of Prematurity

 

Reviewed by Barbara Cormack (Dietitian)
June
2005
Clinical Guidelines Back Newborn Services Home Page
Risk Factors Treatment References

Risk Factors

When an infant is identified to be at risk of osteopenia, measurement of urinary mineral excretion and serum 25-OH D should be considered.

Guidelines for the Treatment of Osteopenia of Prematurity

  1. Prescribe elemental calcium 2.5mmol/kg/day and elemental phosphate 1.6mmol/kg/day to be given in divided doses, four times daily. 
    Calcium and phosphate must not be given at the same time, so in practice should be given at alternate feeds.  
    For example,
    0600hr   Calcium 1.25mmol/kg/dose
    1200hr   Phosphate 0.8mmol/kg/dose
    1800hr   Calcium 1.25mmol/kg/dose
    2400hr   Phosphate 0.8mmol/kg/dose

    As intestinal obstruction has been associated with calcium supplementation of enteral feeds, incremental advancement of calcium and phosphate supplements is recommended starting at 50% of the target dose recommended above.
    Contact the Newborn Unit Pharmacist for directions.

  2. Ensure an adequate intake of calcium and phosphate from feeds:
  3. Ensure a daily intake of 400IU Vitamin D per day.
  4. Weekly monitoring in infants being treated with additional calcium, phosphate, or vitamin D:
  5. Treatment is continued until biochemical indices are normal and radiographic evidence of healing is present.
  6. Consider other nutritional deficiencies (for example zinc) in an infant who is failing to thrive with evidence of significant bone disease.

Caution:

  • Infants on chronic diuretic therapy with loop diuretics (furosemide) are at risk of increased urinary calcium excretion. High urinary calcium increases the risk of nephrocalcinosis.

References

1

Groh-Wargo S, Thompson M, Hovasi Cox J, Hartline J.  Nutritional Care for High-Risk Newborns, 3rd Edition, Illinois, Precept Press, 2000